Oxaliplatin (L-OHP®): A new platinum analog: Active in refractory/relapsed intermediate and low crade non-Hodgkin lymphoma (NHL): A phase I–II study

Authors :: M. Musset
J. Gastiaburu
M. Di Palma
Claude Jasmin
M. Itzhaki
J.L. Misset
M. Robalski
M.P. Lemonnier
S. Brienza
Source :: European Journal of Cancer. 29:S176
Publication Year :: 1993
Publisher :: Elsevier BV, 1993.

Subjects :: Cancer Research
business.industry
chemistry.chemical_element
Oxaliplatin
Phase i ii
Oncology
chemistry
Refractory
medicine
Cancer research
Hodgkin lymphoma
Platinum
business
medicine.drug

Full Text Access

Tools